LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | AZD8055 | 10 | uM | LJP6 | 2 | A07 | 72 | hr | 962 | 50 | 10740 | 0.0047 | -0.5724 |
MCF 10A | AZD8055 | 10 | uM | LJP6 | 3 | A07 | 72 | hr | 962 | 57 | 10641 | 0.0054 | -0.5574 |
MCF 10A | Sorafenib | 0.04 | uM | LJP6 | 1 | B12 | 72 | hr | 962 | 9860 | 10693 | 0.9220 | 0.9538 |
MCF 10A | Sorafenib | 0.04 | uM | LJP6 | 2 | B12 | 72 | hr | 962 | 10008 | 10740 | 0.9318 | 0.9598 |
MCF 10A | Sorafenib | 0.04 | uM | LJP6 | 3 | B12 | 72 | hr | 962 | 10633 | 10641 | 0.9992 | 0.9995 |
MCF 10A | Sorafenib | 0.12 | uM | LJP6 | 1 | B11 | 72 | hr | 962 | 9352 | 10693 | 0.8745 | 0.9243 |
MCF 10A | Sorafenib | 0.12 | uM | LJP6 | 2 | B11 | 72 | hr | 962 | 9335 | 10740 | 0.8691 | 0.9210 |
MCF 10A | Sorafenib | 0.12 | uM | LJP6 | 3 | B11 | 72 | hr | 962 | 10308 | 10641 | 0.9687 | 0.9817 |
MCF 10A | Sorafenib | 0.37 | uM | LJP6 | 1 | B10 | 72 | hr | 962 | 9227 | 10693 | 0.8629 | 0.9169 |
MCF 10A | Sorafenib | 0.37 | uM | LJP6 | 2 | B10 | 72 | hr | 962 | 9103 | 10740 | 0.8475 | 0.9072 |
MCF 10A | Sorafenib | 0.37 | uM | LJP6 | 3 | B10 | 72 | hr | 962 | 9778 | 10641 | 0.9188 | 0.9518 |
MCF 10A | Sorafenib | 1.11 | uM | LJP6 | 1 | B09 | 72 | hr | 962 | 9263 | 10693 | 0.8662 | 0.9190 |
MCF 10A | Sorafenib | 1.11 | uM | LJP6 | 2 | B09 | 72 | hr | 962 | 9274 | 10740 | 0.8634 | 0.9174 |
MCF 10A | Sorafenib | 1.11 | uM | LJP6 | 3 | B09 | 72 | hr | 962 | 9866 | 10641 | 0.9271 | 0.9568 |
MCF 10A | Sorafenib | 3.33 | uM | LJP6 | 1 | B08 | 72 | hr | 962 | 8784 | 10693 | 0.8214 | 0.8899 |
MCF 10A | Sorafenib | 3.33 | uM | LJP6 | 2 | B08 | 72 | hr | 962 | 9239 | 10740 | 0.8602 | 0.9153 |
MCF 10A | Sorafenib | 3.33 | uM | LJP6 | 3 | B08 | 72 | hr | 962 | 9340 | 10641 | 0.8777 | 0.9261 |
MCF 10A | Sorafenib | 10 | uM | LJP6 | 1 | B07 | 72 | hr | 962 | 4395 | 10693 | 0.4110 | 0.5484 |
MCF 10A | Sorafenib | 10 | uM | LJP6 | 2 | B07 | 72 | hr | 962 | 4047 | 10740 | 0.3768 | 0.5109 |
MCF 10A | Sorafenib | 10 | uM | LJP6 | 3 | B07 | 72 | hr | 962 | 4801 | 10641 | 0.4512 | 0.5898 |
MCF 10A | CP466722 | 0.04 | uM | LJP5 | 1 | I12 | 72 | hr | 962 | 10975 | 10714 | 1.0244 | 1.0139 |
MCF 10A | CP466722 | 0.04 | uM | LJP5 | 2 | I12 | 72 | hr | 962 | 10592 | 10507 | 1.0080 | 1.0046 |
MCF 10A | CP466722 | 0.04 | uM | LJP5 | 3 | I12 | 72 | hr | 962 | 10313 | 10315 | 0.9998 | 0.9999 |
MCF 10A | CP466722 | 0.12 | uM | LJP5 | 1 | I11 | 72 | hr | 962 | 10658 | 10714 | 0.9948 | 0.9970 |
MCF 10A | CP466722 | 0.12 | uM | LJP5 | 2 | I11 | 72 | hr | 962 | 10405 | 10507 | 0.9902 | 0.9943 |